Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
International Journal of Molecular Sciences
|
October 14, 2022
Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy
I-Cheng Lee, Keng-Hsin Lan, Chien-Wei Su, et al.
Cancers
|
September 10, 2021
Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection
Chen-Ta Chi, I-Cheng Lee, Rheun-Chuan Lee, et al.
Journal of Viral Hepatitis
|
August 21, 2018
Risk of renal events during tenofovir disoproxil fumarate and entecavir antiviral prophylaxis in HBsAg-positive cancer patients undergoing chemotherapy
I-Cheng Lee, Yee Chao, Chung-Pin Li, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 19, 2020
Virological and immunological predictors of long term outcomes of peginterferon alfa-2a therapy for HBeAg-negative chronic hepatitis B
I-Cheng Lee, Chien-Wei Su, Keng-Hsin Lan, et al.
Cancer Immunology, Immunotherapy : CII
|
March 29, 2022
Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma
Chi-Jung Wu, Pei-Chang Lee, Ya-Wen Hung, et al.
Journal of the Chinese Medical Association : JCMA
|
October 20, 2021
Outcomes of patients with malignant esophagogastric junction obstruction receiving metallic stents: A single-center experience
Yu-Ling Pan, Pei-Shan Wu, Bing-Wei Ye, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
June 8, 2019
Outcomes of enteral metallic stent in patients with pancreatic carcinoma and gastric outlet obstruction: A single center experience
Ke-Bin Chang, Bing-Wei Ye, Chung-Kai Chou, et al.
Medicine
|
April 11, 2015
Determinants of survival after sorafenib failure in patients with BCLC-C hepatocellular carcinoma in real-world practice
I-Cheng Lee, Yi-Tzen Chen, Yee Chao, et al.
Cancers
|
January 17, 2020
Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma
Pei-Chang Lee, Yee Chao, Ming-Huang Chen, et al.
Viruses
|
November 11, 2022
Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment
I-Cheng Lee, Pei-Chang Lee, Yee Chao, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
International Journal of Molecular Sciences
|
October 14, 2022
Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy
I-Cheng Lee, Keng-Hsin Lan, Chien-Wei Su, et al.
Cancers
|
September 10, 2021
Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection
Chen-Ta Chi, I-Cheng Lee, Rheun-Chuan Lee, et al.
Journal of Viral Hepatitis
|
August 21, 2018
Risk of renal events during tenofovir disoproxil fumarate and entecavir antiviral prophylaxis in HBsAg-positive cancer patients undergoing chemotherapy
I-Cheng Lee, Yee Chao, Chung-Pin Li, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 19, 2020
Virological and immunological predictors of long term outcomes of peginterferon alfa-2a therapy for HBeAg-negative chronic hepatitis B
I-Cheng Lee, Chien-Wei Su, Keng-Hsin Lan, et al.
Cancer Immunology, Immunotherapy : CII
|
March 29, 2022
Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma
Chi-Jung Wu, Pei-Chang Lee, Ya-Wen Hung, et al.
Journal of the Chinese Medical Association : JCMA
|
October 20, 2021
Outcomes of patients with malignant esophagogastric junction obstruction receiving metallic stents: A single-center experience
Yu-Ling Pan, Pei-Shan Wu, Bing-Wei Ye, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
June 8, 2019
Outcomes of enteral metallic stent in patients with pancreatic carcinoma and gastric outlet obstruction: A single center experience
Ke-Bin Chang, Bing-Wei Ye, Chung-Kai Chou, et al.
Medicine
|
April 11, 2015
Determinants of survival after sorafenib failure in patients with BCLC-C hepatocellular carcinoma in real-world practice
I-Cheng Lee, Yi-Tzen Chen, Yee Chao, et al.
Cancers
|
January 17, 2020
Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma
Pei-Chang Lee, Yee Chao, Ming-Huang Chen, et al.
Viruses
|
November 11, 2022
Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment
I-Cheng Lee, Pei-Chang Lee, Yee Chao, et al.
Page
of 7